Multi-omics biomarker pipeline reveals elevated levels of protein-glutamine gamma-glutamyltransferase 4 in seminal plasma of prostate cancer patients
A. P. Drabovich, P. Saraon, M. Drabovich, T. D. Karakosta, A. Dimitromanolakis, M. E. Hyndman, K. Jarvi, E. P. Diamandis
The paper identifies TGM4 as a potential biomarker in seminal plasma for prostate cancer detection and prognosis, outperforming PSA and age in some cases.
bioRxiv · May 7, 2018Cancer Biology